Use Options For a Chance To Buy ITCI at a 69% Discount
August 06, 2015 at 11:46 AM EDT
Looking back to 154 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 4,750,000 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 25.2% above the offering price..